Back to US BANCORP \DE\ US BANCORP \DE\

RNTXRNTX
14 quarters

Position history for US BANCORP \DE\US BANCORP \DE\'s holdings in REIN THERAPEUTICS INC

US BANCORP \DE\ holds 1,250 shares of RNTX (REIN THERAPEUTICS INC), worth $1,625 as of 2026-Q1.

Current Value

$1,625

Current Shares

1,250

Total Value Change

-$1,338

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
1,250
0.0%
$1,6250.0%$1.15
0
2025-Q4
Unchanged
1,250
0.0%
$1,4500.0%$1.07
0
2025-Q3
Unchanged
1,250
0.0%
$1,4310.0%$1.15
0
2025-Q2
Unchanged
1,250
0.0%
$1,7500.0%$1.47
0
2025-Q1
Unchanged
1,250
0.0%
$2,2130.0%$1.70
0
2024-Q4
Unchanged
1,250
0.0%
$2,8750.0%$2.32
0
2024-Q3
Unchanged
1,250
0.0%
$4,4250.0%$3.65
0
2024-Q2
Unchanged
1,250
0.0%
$3,4630.0%$2.77
0
2024-Q1
Unchanged
1,250
0.0%
$8,2880.0%$6.63
0
2023-Q4
Unchanged
1,250
0.0%
$3,8110.0%$3.05
0
2023-Q3
Unchanged
1,250
0.0%
$1,9000.0%$1.52
0
2023-Q2
Unchanged
1,250
0.0%
$2,2380.0%$1.78
0
2023-Q1
Unchanged
1,250
0.0%
$1,5500.0%$1.26
0
2022-Q4
New
1,250
-
$2,9630.0%$2.37
20

Other major holders of RNTX: Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used